Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance
Crossref DOI link: https://doi.org/10.1038/bcj.2017.81
Published Online: 2017-09-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosenberg, A S
Brunson, A
Paulus, J K
Tuscano, J
Wun, T
Keegan, T H M
Jonas, B A
Text and Data Mining valid from 2017-09-08
Version of Record valid from 2017-09-08
Article History
Received: 3 July 2017
Accepted: 20 July 2017
First Online: 8 September 2017
Competing interests
: The authors declare no conflict of interest.